Science

Constipation Drug Shows Unexpected Power to Protect Kidneys in Clinical Trial

Lubiprostone appears to slow kidney function decline in patients with moderate chronic kidney disease by improving gut bacteria.

Constipation Drug Shows Unexpected Power to Protect Kidneys in Clinical Trial
Read the full reporting at ScienceDaily Top.

Originally reported by ScienceDaily Top.

chronic kidney disease lubiprostone gut microbiome spermidine mitochondria clinical trial